LETTER: Guam archbishop seeks prayers for cardinals, conclave to elect a new pope. Pacific Daily News; ... We'd love to hear eyewitness accounts, the history behind an article.

LETTER: Addressing the growing concerns of drug use in Tonga. By Luisa Finau; Apr 11, 2025 ... We'd love to hear eyewitness accounts, the history behind an article. Post a comment.

The 69th Eurovision Song Contest had a seriously dramatic finish – one that probably gave organisers a minor heart attack. Following another year in which this strenuously non-political event was ...

*Refers to the latest 2 years of stltoday.com stories. Cancel anytime. As a small business owner, I am writing to express my strong opposition to the mandatory sick time requirement included in ...

I write this letter in support of Mrs. Anna Huit for the position of North Bend School Board Member. I have known Anna and her family for several years. She ...

If today’s self-proclaimed conservatives had been around in 1773, they wouldn’t have been tossing tea into Boston Harbor — they’d have been guarding the crates for the crown and calling ...

On May 20, voters have a chance to change the course of Bay Area Hospital’s future. I strongly encourage you to vote for Dr. John Uno, Brandon Saada, Kyle Stevens, ...

The Army will transform to a leaner, more lethal force by adapting how we fight, train, organize, and buy equipment.

Henry Hinton, host of Talk of the Town and owner of Inner Banks Media, sent a letter to Greenville City Council members Portia Willis, Tanya Foreman, Marion Blackburn and Matt Scully this morning.

I'd like to try to help David Wolf be less confused about the motives of the 2,500 or so protesters at Flagstaff City Hall on April 5 at the Hands Off rally. Speaking only for myself, but assuming ...

On a recent visit to Brightside Bookstore, I planned to swing by quickly to pick up a book I had ordered. But after 10 minutes of circling for parking, I ...

WESTON, Fla., April 24, 2025 (GLOBE NEWSWIRE) -- ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA; “ZyVersa”), a clinical stage specialty biopharmaceutical company developing first-in-class drugs for ...